Insider Transactions in Q2 2022 at Mimedx Group, Inc. (MDXG)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2022
|
Robert Benjamin Stein President, Regenerative Med. |
SELL
Open market or private sale
|
Direct |
14,600
-4.19%
|
$43,800
$3.47 P/Share
|
|
Jun 10
2022
|
Michael J Giuliani Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,191
+31.8%
|
$132,573
$3.96 P/Share
|
|
Jun 09
2022
|
Timothy R Wright Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
112,000
-6.14%
|
$336,000
$3.75 P/Share
|
|
Jun 07
2022
|
M Kathleen Behrens Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,191
+26.02%
|
$132,573
$3.96 P/Share
|
|
Jun 07
2022
|
James L Bierman Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,191
+26.02%
|
$132,573
$3.96 P/Share
|
|
Jun 07
2022
|
Phyllis Gardner Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,191
+35.11%
|
$132,573
$3.96 P/Share
|
|
Jun 07
2022
|
William A Hawkins Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,191
+27.44%
|
$132,573
$3.96 P/Share
|
|
Jun 07
2022
|
Cato T Laurencin Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,191
+31.8%
|
$132,573
$3.96 P/Share
|
|
Jun 07
2022
|
Todd Newton Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,191
+26.02%
|
$132,573
$3.96 P/Share
|
|
May 09
2022
|
Mark Graves SVP & Chief Compliance Officer |
SELL
Open market or private sale
|
Direct |
3,891
-2.83%
|
$11,673
$3.5 P/Share
|
|
May 06
2022
|
William Lawrence Phelan Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,750
-3.82%
|
$17,250
$3.81 P/Share
|
|
May 02
2022
|
Scott M Turner SVP, Operations & Procurement |
SELL
Open market or private sale
|
Direct |
5,260
-2.27%
|
$21,040
$4.0 P/Share
|
|
Apr 08
2022
|
Robert Benjamin Stein President, Regenerative Med. |
BUY
Grant, award, or other acquisition
|
Direct |
178,571
+33.87%
|
$714,284
$4.62 P/Share
|
|
Apr 08
2022
|
Peter M Carlson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
187,500
+24.75%
|
$750,000
$4.62 P/Share
|
|
Apr 08
2022
|
Rohit Kashyap President, WC & Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
178,571
+28.76%
|
$714,284
$4.62 P/Share
|
|
Apr 08
2022
|
William Lawrence Phelan Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,030
+26.07%
|
$212,120
$4.62 P/Share
|
|
Apr 08
2022
|
Scott M Turner SVP, Operations & Procurement |
BUY
Grant, award, or other acquisition
|
Direct |
61,472
+20.95%
|
$245,888
$4.62 P/Share
|
|
Apr 08
2022
|
Mark Graves SVP & Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,485
+26.07%
|
$193,940
$4.62 P/Share
|
|
Apr 08
2022
|
William Frank Iv Hulse General Counsel and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
178,571
+32.86%
|
$714,284
$4.62 P/Share
|
|
Apr 08
2022
|
Timothy R Wright Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
602,679
+24.84%
|
$2,410,716
$4.62 P/Share
|